Terence Rooney
CIK: 0002146464
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KYMR
Kymera Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Rooney Terence
Rooney Terence (SEC CIK 0002146464) files insider reports with the SEC as Chief Medical Officer of Kymera Therapeutics, Inc. (KYMR).
Signal8 holds 2 ownership filings by Rooney Terence (1 Form 3, 1 Form 4), filed on Jul 27, 2026. Those filings report 1 transaction, the latest on Jul 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rooney Terence's filings is in WATERTOWN, MA.
Recent filings by Rooney Terence
- Jul 27, 2026: Grant or award of KYMR shares (Form 4, code A).
Other insiders filing for Kymera Therapeutics, Inc. (KYMR)
- Mainolfi Nello, Chief Executive Officer
- Adams Brian, Chief Legal Officer
- Jacobs Bruce N., Chief Financial Officer
- Goodman Noah, Chief Business Officer
- Booth Bruce, Director
- BVF PARTNERS L P/IL, Director